NDC 68254-5012-01 - TOFACITINIB CITRATE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
68254-5012
Requested NDC
68254-5012-01
Package NDCs from labels
68254-5012-1, 68254-5012-3, 68254-5012-2, 68254-5012-01
Manufacturer
CONCORD BIOTECH LIMITED
Effective date
2026-10-16
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
TOFACITINIB CITRATE - CONCORD BIOTECH LIMITEDCONCORD BIOTECH LIMITED2026-10-16HUMAN PRESCRIPTION DRUG LABEL

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 112 · 2,224 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HERA SILKYSTAY FOUNDATION 17W1TITANIUM DIOXIDEAmorepacific Corporation5eb39387-7f6b-ce78-e063-6394a90a15ae2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 21C2TITANIUM DIOXIDEAmorepacific Corporation5eb3c3ad-8a77-0655-e063-6394a90ae9e02026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 21N1TITANIUM DIOXIDEAmorepacific Corporation5eb3ddb5-4e2b-17d4-e063-6394a90aaa552026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 22N1TITANIUM DIOXIDEAmorepacific Corporation5eb415b3-b1ba-42b8-e063-6394a90a90d72026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 21W1TITANIUM DIOXIDEAmorepacific Corporation5eb42062-f298-5186-e063-6294a90ab0432026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 23C2TITANIUM DIOXIDEAmorepacific Corporation5eb44e1b-b24b-6c83-e063-6394a90a4b522026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 23W1TITANIUM DIOXIDEAmorepacific Corporation5eb468db-3c38-922d-e063-6294a90adef82026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 24N1TITANIUM DIOXIDEAmorepacific Corporation5eb4b8ca-eced-b7ff-e063-6394a90aaefe2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 24O1TITANIUM DIOXIDEAmorepacific Corporation5eb4f87a-b4dc-1aa5-e063-6294a90a2ec42026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 25W1TITANIUM DIOXIDEAmorepacific Corporation5eb50784-444e-3bf3-e063-6294a90aa6182026-10-25WarningsExact identifier
unii: 15FIX9V2JP
TofacitinibTOFACITINIBMacleods Pharmaceuticals Limited9b654f0d-7705-4880-9e9d-ad3a51e56b562026-10-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2048566
rxcui: 1357541
unii: O1FF4DIV0D
TofacitinibTOFACITINIBApotex Corp.7d4f5cfa-35a8-1458-a609-f6b417946abb2026-10-21Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2048566
rxcui: 1357541
KARYNG Complete SPF Sunscreen Medium/DarkSUNSCREENKaryng LLC335eee1e-ef1c-41da-e063-6294a90ac2732026-10-20WarningsExact identifier
unii: 15FIX9V2JP
KARYNG Complete SPF Sunscreen Light/MediumSUNSCREENKaryng LLC33596253-413d-fba3-e063-6394a90a39e42026-10-19WarningsExact identifier
unii: 15FIX9V2JP
TOFACITINIB CITRATETOFACITINIB CITRATEStellon Biotech Inc.89eb2ffc-02d9-4b46-b480-e9b10af330272026-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA218821
rxcui: 2048566
rxcui: 1357541
unii: O1FF4DIV0D
TOFACITINIBTOFACITINIBSun Pharmaceutical Industries, Inc.a764a133-b870-4514-bbee-24d43f8cb7fd2026-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O1FF4DIV0D
ALEX MD PHD Sheer Mineral SunscreenZINC OXIDE, TITANIUM DIOXIDEPHYSICIAN LABORATORIES INC8f64c4fa-92ee-4af0-ab1b-6c3673f9a6222026-10-16WarningsExact identifier
unii: 15FIX9V2JP
ALEX MD PHD Tinted Mineral SunscreenZINC OXIDE, TITANIUM DIOXIDEPHYSICIAN LABORATORIES INC93873c34-5c72-43c8-b6c2-c65b596191d72026-10-16WarningsExact identifier
unii: 15FIX9V2JP
TOFACITINIB CITRATETOFACITINIB CITRATECONCORD BIOTECH LIMITED6c33e5b4-4843-4a80-a4f8-435bfceddc2a2026-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA218821
ndc (package): 68254-5012-3
ndc (package): 68254-5012-1
ndc (package): 68254-5011-1
ndc (package): 68254-5011-2
ndc (package): 68254-5012-2
ndc (product): 68254-5012
ndc (product): 68254-5011
ndc11 (package): 68254501201
rxcui: 2048566
rxcui: 1357541
spl id: ad6e5467-da25-405d-a725-c95489d79aab
spl set id: 6c33e5b4-4843-4a80-a4f8-435bfceddc2a
unii: O1FF4DIV0D
TofacitinibTOFACITINIBSaptalis Pharmaceuticals, LLC.c6c033ff-bce0-4d1c-a182-3b13191686e12026-10-15Boxed warning, Warnings, Adverse reactionsExact identifier
unii: O1FF4DIV0D

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.